BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27921455)

  • 1. Lipoprotein profiling methodology based on determination of apolipoprotein concentration.
    Takeda H; Izumi Y; Tomita A; Koike T; Shiomi M; Fukusaki E; Matsuda F; Bamba T
    Bioanalysis; 2017 Jan; 9(1):9-19. PubMed ID: 27921455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic analysis of plasma lipoprotein fractions in myocardial infarction-prone rabbits.
    Takeda H; Koike T; Izumi Y; Yamada T; Yoshida M; Shiomi M; Fukusaki E; Bamba T
    J Biosci Bioeng; 2015 Oct; 120(4):476-82. PubMed ID: 26162515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FT-IR spectroscopy of lipoproteins--a comparative study.
    Krilov D; Balarin M; Kosović M; Gamulin O; Brnjas-Kraljević J
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Aug; 73(4):701-6. PubMed ID: 19414281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core lipid, surface lipid and apolipoprotein composition analysis of lipoprotein particles as a function of particle size in one workflow integrating asymmetric flow field-flow fractionation and liquid chromatography-tandem mass spectrometry.
    Kuklenyik Z; Jones JI; Gardner MS; Schieltz DM; Parks BA; Toth CA; Rees JC; Andrews ML; Carter K; Lehtikoski AK; McWilliams LG; Williamson YM; Bierbaum KP; Pirkle JL; Barr JR
    PLoS One; 2018; 13(4):e0194797. PubMed ID: 29634782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
    Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
    Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of Lipoprotein Subclasses by Charge Detection Mass Spectrometry.
    Lutomski CA; Gordon SM; Remaley AT; Jarrold MF
    Anal Chem; 2018 Jun; 90(11):6353-6356. PubMed ID: 29756771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative characteristics of plasma lipoproteins and mesenteric lymph in the rabbit: spectrum and chemical properties].
    Denisenko AD; Lozovskiĭ VT; Bergmann S; Iaros V; Klimov AN
    Vopr Med Khim; 1984; 30(5):65-72. PubMed ID: 6528523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
    Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
    J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins.
    Heller M; Stalder D; Schlappritzi E; Hayn G; Matter U; Haeberli A
    Proteomics; 2005 Jul; 5(10):2619-30. PubMed ID: 15892164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of the lipoprotein structure in the St. Thomas' Mixed Hyperlipidaemic (SMHL) rabbit.
    de Roos B; Caslake MJ; Milliner K; Benson GM; Suckling KE; Packard CJ
    Atherosclerosis; 2005 Jul; 181(1):63-8. PubMed ID: 15939055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
    Chiuve SE; Martin LA; Campos H; Sacks FM
    J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography.
    Okazaki M; Usui S; Ishigami M; Sakai N; Nakamura T; Matsuzawa Y; Yamashita S
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):578-84. PubMed ID: 15637308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women.
    Campos H; Walsh BW; Judge H; Sacks FM
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3955-63. PubMed ID: 9398695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins.
    Xie Y; Nassir F; Luo J; Buhman K; Davidson NO
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G735-46. PubMed ID: 12816761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of the analysis of lipoproteins after myocardial infarction].
    Dewailly P; Mellin D; Moulin S; Rouget JP; Sezille G; Jaillard J
    Presse Med; 1983 Jul 9-16; 12(29):1807-10. PubMed ID: 6224195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.